Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Retained Earnings: 2009-2024

Historic Retained Earnings for Rockwell Medical (RMTI) over the last 16 years, with Dec 2024 value amounting to -$397.7 million.

  • Rockwell Medical's Retained Earnings fell 1.39% to -$402.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$402.4 million, marking a year-over-year decrease of 1.39%. This contributed to the annual value of -$397.7 million for FY2024, which is 0.12% down from last year.
  • Per Rockwell Medical's latest filing, its Retained Earnings stood at -$397.7 million for FY2024, which was down 0.12% from -$397.2 million recorded in FY2023.
  • Rockwell Medical's 5-year Retained Earnings high stood at -$337.4 million for FY2020, and its period low was -$397.7 million during FY2024.
  • In the last 3 years, Rockwell Medical's Retained Earnings had a median value of -$397.2 million in 2023 and averaged -$394.5 million.
  • Data for Rockwell Medical's Retained Earnings shows a maximum YoY declined of 10.08% (in 2020) over the last 5 years.
  • Over the past 5 years, Rockwell Medical's Retained Earnings (Yearly) stood at -$337.4 million in 2020, then dropped by 9.68% to -$370.1 million in 2021, then dropped by 5.05% to -$388.8 million in 2022, then declined by 2.17% to -$397.2 million in 2023, then declined by 0.12% to -$397.7 million in 2024.